Prognostic significance of WT1 gene expression in pediatric acute myeloid leukemia
暂无分享,去创建一个
J. A. Yunes | S. Brandalise | M. Viana | A. Nowill | E. Matsuda | Patricia C. Rodrigues | S. Oliveira
[1] W. Hiddemann,et al. Prognostic impact of RT-PCR-based quantification of WT1 gene expression during MRD monitoring of acute myeloid leukemia , 2005, Leukemia.
[2] T. Naoe,et al. Multiplex Real-time RT–PCR for Prospective Evaluation of WT1 and Fusion Gene Transcripts in Newly Diagnosed De Novo Acute Myeloid Leukemia , 2004, Leukemia & lymphoma.
[3] J. Rowe,et al. The relationship of patient age to the pathobiology of the clonal myeloid diseases. , 2004, Seminars in oncology.
[4] F. Watzinger,et al. Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using ‘real-time’ quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) – a Europe against cancer program , 2003, Leukemia.
[5] Marcos Borato Viana,et al. Leucemia mielóide aguda na criança: experiência de 15 anos em uma única instituição , 2003 .
[6] K. Tobal,et al. Prognostic significance of quantitative analysis of WT1 gene transcripts by competitive reverse transcription polymerase chain reaction in acute leukaemia , 2003, British journal of haematology.
[7] A. Levis,et al. Significant correlation between the degree of WT1 expression and the International Prognostic Scoring System Score in patients with myelodysplastic syndromes. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] D. Cilloni,et al. Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients , 2002, Leukemia.
[9] O. Hrusak,et al. Real-time quantitative PCR detection of WT1 gene expression in children with AML: prognostic significance, correlation with disease status and residual disease detection by flow cytometry , 2002, Leukemia.
[10] N. Hosen,et al. patients with hematopoietic malignancies product in WT 1 Humoral immune responses against Wilms tumor gene , 2002 .
[11] Wei Huang,et al. Utility of WT1 as a Reliable Tool for the Detection of Minimal Residual Disease in Children with Leukemia , 2002, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.
[12] D. Haber,et al. The Wilms tumor suppressor WT1 directs stage‐specific quiescence and differentiation of human hematopoietic progenitor cells , 2001, The EMBO journal.
[13] D. Haber,et al. Wilms tumor and the WT1 gene. , 2001, Experimental cell research.
[14] L. Frati,et al. Wilms' Tumor Gene Expression by Normal and Malignant Human B Lymphocytes , 2000, Leukemia & lymphoma.
[15] E. Macintyre,et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease , 1999, Leukemia.
[16] B. Kornhuber,et al. wt1 Gene Expression in Childhood Leukemias , 1999, Acta Haematologica.
[17] G. Heinze,et al. Wilms' tumour gene (wt1) expression at diagnosis has no prognostic relevance in childhood acute lymphoblastic leukaemia treated by an intensive chemotherapy protocol , 1999, European journal of haematology.
[18] 玉置 広哉. The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes , 1999 .
[19] G. Kong,et al. Expression of Wilms tumor gene (WT1) in children with acute leukemia. , 1999, Pediatric hematology and oncology.
[20] M. Tomonaga,et al. The Wilms’ tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes , 1999, Leukemia.
[21] G. Henze,et al. Definition of a standard‐risk group in children with AML , 1999, British journal of haematology.
[22] F. Watzinger,et al. Multiplex PCR for quality control of template RNA/cDNA in RT-PCR assays , 1998, Leukemia.
[23] U. Maurer,et al. Wilms tumor gene (wt1) mRNA is equally expressed in blast cells from acute myeloid leukemia and normal CD34+ progenitors. , 1997, Blood.
[24] U. Maurer,et al. The Wilms' tumor gene is expressed in a subset of CD34+ progenitors and downregulated early in the course of differentiation in vitro. , 1997, Experimental hematology.
[25] U. Maurer,et al. High levels of Wilms' tumor gene (wt1) mRNA in acute myeloid leukemias are associated with a worse long-term outcome. , 1997, Blood.
[26] H. Menssen,et al. Wilms' tumor gene expression in human CD34+ hematopoietic progenitors during fetal development and early clonogenic growth. , 1997, Blood.
[27] G. Heinze,et al. Prognostic significance of WT1 gene expression at diagnosis in adult de novo acute myeloid leukemia , 1997, Leukemia.
[28] P. Baird,et al. Expression of the Wilms' tumor gene (WT1) in normal hemopoiesis. , 1997, Experimental hematology.
[29] Y. Sonoda,et al. Aberrant overexpression of the Wilms tumor gene (WT1) in human leukemia. , 1997, Blood.
[30] T. Kyo,et al. Long-term follow-up of minimal residual disease in leukemia patients by monitoring WT1 (Wilms tumor gene) expression levels. , 1996, Blood.
[31] S. Santillana,et al. High frequency of acute promyelocytic leukemia among Latinos with acute myeloid leukemia. , 1996, Blood.
[32] E. Thiel,et al. Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias. , 1995, Leukemia.
[33] T. Akiyama,et al. WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. , 1994, Blood.
[34] G. Saunders,et al. Expression of the Wilms' tumor gene (WT1) in human leukemias. , 1992, Leukemia.
[35] D. Haber,et al. WT1: a novel tumor suppressor gene inactivated in Wilms' tumor. , 1992, The New biologist.
[36] J. Ritter,et al. Identification of two risk groups in childhood acute myelogenous leukemia after therapy intensification in study AML-BFM-83 as compared with study AML-BFM-78. AML-BFM Study Group. , 1990, Blood.
[37] D. Housman,et al. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus , 1990, Cell.
[38] P. Chomczyński,et al. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.
[39] G Flandrin,et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. , 1985, Annals of internal medicine.
[40] H. Gralnick,et al. Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative Group , 1976, British journal of haematology.
[41] P. Bolufer,et al. Prognostic implications of Wilms' tumor gene (WT1) expression in patients with de novo acute myeloid leukemia. , 2004, Haematologica.
[42] S. Preston‐Martin,et al. High frequency of acute promyelocytic leukemia among Latinos with acute myeloid leukemia. , 1996, Blood.
[43] A. Hagenbeek,et al. Minimal Residual Disease in Acute Leukemia , 1984, Developments in Oncology.
[44] M. Viana,et al. Acute myeloid leukemia in childhood : fifteen-year experience in a single institution , 2022 .